Possible AD | Non-AD | |
---|---|---|
A. Analysis of association of TBI with development of dementia with possible AD | ||
Age | 80.9 ± 6.7 | 70.1 ± 10.1 |
Sex | ||
Male | 62,951 | 556,525 |
Female | 1388 | 31,920 |
Ethnicity | ||
Caucasian | 51,884 | 445,237 |
African American | 6779 | 97,782 |
Hispanic | 4565 | 30,581 |
Other | 1111 | 14,845 |
B. Analysis of association of medications with development of dementia with possible AD after TBI occurrence | ||
Age | 76.9 ± 8.5 | 64.5 ± 9.8 |
Sex | ||
Male | 310 | 5663 |
Female | 17 | 710 |
Ethnicity | ||
White | 228 | 4431 |
African American | 35 | 1243 |
Hispanic | 57 | 506 |
Other | 7 | 193 |
Medication | ||
No med | 92 | 1957 |
ACEI | 47 | 644 |
Beta blocker | 35 | 868 |
Metformin | 29 | 403 |
Statin | 57 | 1105 |
ACEI + beta blocker | 15 | 262 |
ACEI + metformin | 2 | 133 |
ACEI + statin | 14 | 359 |
Beta blocker + statin | 21 | 394 |
Beta blocker + metformin | 3 | 89 |
Metformin + statin | 12 | 159 |